Skip to main content
. 2024 Oct 1;44(12):3151–3163. doi: 10.1111/liv.16076

TABLE 3.

Patient characteristics at the confirmation of sustained virological response (SVR).

Available data, n (%) Overall (n = 326)
Patient characteristics
Sex, n (%)
Female 326 (100) 204 (62.6)
Male 122 (37.4)
LSM (kPa), median (IQR) 116 (35.6) 5.9 (4.4–10.4)
LSM ≥ 10 kPa, n (%) 30 (9.2)
LSM ≥ 15 kPa, n (%) 17 (5.2)
LSM ≥ 25 kPa, n (%) 8 (2.5)
CAP (dB/m), median (IQR) 226 (192–271)
CAP ≥248 dB/m, n (%) 37 (11.3)
CAP >275 dB/m, n (%) 23 (7.1)
APRI score, median (IQR) 0.26 (0.18–0.37)
<0.5, n (%) 209 (64.1) 176 (54.0)
<1.0, n (%) 193 (59.2)
>1.5, n (%) 8 (2.5)
>2.0, n (%) 5 (1.5)
FIB‐4 score, median (IQR) 1.34 (0.84–1.96)
<1.3, n (%) 207 (63.5) 100 (30.7)
1.3–2.67, n (%) 80 (24.5)
>2.67, n (%) 27 (8.3)
Haemoglobin (g/dL), mean (SD) 212 (65.0) 13.9 (1.6)
Platelet count (G/L), median (IQR) 212 (65.0) 209 (168–255)
WBC (G/L), median (IQR) 212 (65.0) 6.7 (5.4–8.4)
INR, mean (SD) 193 (59.2) 1.1 (0.2)
Bilirubin (mg/dL), median (IQR) 212 (65.0) 0.4 (0.3–0.7)
Albumin (mg/dL), mean (SD) 209 (64.1) 44.0 (4.2)
AST (IU/L), median (IQR) 205 (62.9) 23 (18–29)
ALT (IU/L), median (IQR) 205 (62.9) 20 (14–27)
>ULN, n (%) 13 (4.0)
AP (IU/L), median (IQR) 212 (65.0) 75 (62–93)
gGT (IU/L), median (IQR) 212 (65.0) 21 (15–35)
> ULN, n (%) 28 (8.6)
CRP (mg/dL), median (IQR) 149 (58) 0.1 (0.1–0.4)

Abbreviations: ALT, alanine aminotransferase; AP, alkaline phosphatase; APRI, AST to PLT ratio‐index; AST, aspartate aminotransferase; CAP, continuous attenuation parameter; CRP, C‐reactive protein; gGT, gammaglutamyl transferase; HCV, hepatitis C virus; INR, international normalised ratio; IQR, interquartile range; LSM, liver stiffness measurement; n, number; SD, standard deviation; SVR, sustained virological response; ULN, upper limit of normal; WBC, white‐cell blood count.